Dividend23 May 2026, 08:00 pm
Anupam Rasayan Recommends ₹1.5 Dividend for FY26
AI Summary
The Board of Directors of Anupam Rasayan India Ltd approved and recommended a final dividend of ₹1.5 per equity share (15% of face value of ₹10 each) for the financial year 2025-26, subject to shareholder approval at the upcoming AGM. The board also approved the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. Other approvals include the reappointment of internal and cost auditors, a proposed acquisition of up to 74.20% of Bliss GVS Pharma Limited, and raising funds via NCDs up to ₹160 Crore.
Key Highlights
- Anupam Rasayan recommends a final dividend of ₹1.5 per share for FY26.
- Audited financial results for FY26 were approved with an unmodified opinion from the statutory auditor.
- The company plans to acquire up to 74.20% stake in Bliss GVS Pharma Limited.
- Board approved raising up to ₹160 Crore through Non-Convertible Debentures (NCDs).
- Vishal Thakkar resigned from the post of Deputy CFO and Key Managerial Personnel.
Price Impact
More from ANURAS